🇺🇸 FDA
Patent

US 7491802

Anti-BAMBI antibody and diagnostic or remedy for colon cancer and liver cancer

granted A61PA61P35/00

Quick answer

US patent 7491802 (Anti-BAMBI antibody and diagnostic or remedy for colon cancer and liver cancer) held by Takeda Pharmaceutical Company Limited expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Feb 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P35/00